Kalaris Therapeutics, Inc. — Balance Sheet Charts
3 snapshots of history · ending 2019-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets
$139M
Current Assets
$127M
Cash & Equivalents
$61M
ST Investments
$65M
Net PPE
$350K
Total Liabilities
$18M
Current Liabilities
$9M
Account Payables
$630K
Stockholders Equity
$-52M
Retained Earnings
$-55M
Operating Lease ROU Asset
$12M
Operating Lease Liability
$9M
Gross PP&E
$369K
Accumulated Depreciation
$19K
Contract Liability
—